Central Hospital of Jinzhou President Liu Jianxin, Director Zhao Jin and others visit Shenyang Cell Center

In the afternoon of March 28, Central Hospital of Jinzhou President Liu Jianxin, Director Zhao Jin and others visited Shenyang Cell Center, and was warmly received by Professor Yu Yanqiu, President of the Center, and the medical staff.

 

 

In the VIP room on the 3rd floor of the company building, President Yu Yanqiu expressed the warmest welcome to President Liu Jianxin, all the experts and accompanying visitors, introduced a series of industry qualifications and honors achieved by Shenyang Cell Center, discussed the latest research results in the field of cell therapy and about the prospects for their application with the visitors. They also talked about the cell industry in the Northeast region, about the planning and development of the industry.

 

 

President Liu Jianxin highly praised the Center’s excellent achievements and future industrial planning and development in the cell industry. The two sides fully exchanged their opinions on cooperating in the industrialization of cell therapy and clinical applications to do a full exchange of information. They  looked forward to in-depth exchanges in the future around the cooperation scenarios in the field of life and health industry, to promote further cooperation and seek common development.

 

 

In recent years, China has made outstanding achievements in the field of regenerative medicine in the cell industry, not only leaping to the forefront of the world, but also showing the potential to lead the global innovation era. In the future, it is expected that the two sides can further strengthen communication and cooperation, jointly explore the road of integration and development of healthcare and regenerative medicine, and contribute more wisdom and strength to the development of the Northeast region.

 

Shenyang Cell Center will continue to contribute fully as the leader of cell industry, focusing on the development path of independent and continuous innovation, conducting in-depth research and exploration in the field of cell regeneration, providing more quality services for the society, people, and partners, and practicing the responsibility and commitment to the development of the cell industry.